Human-plant hybrid cells reveal most dna activity is noise

Scientists have used human cells fused with plant DNA to test the purpose of non-coding DNA in the human genome. The experiment shows that activity in this so-called 'dark DNA' is largely random noise, supporting the idea that much of it is junk. The findings challenge claims that high activity implies function.

For decades, biologists have debated the role of non-coding DNA, which makes up about 98.8 percent of the human genome. While a 2012 project called ENCODE suggested over 80 percent of the genome is active—implying importance—others argued this activity could be mere noise.

In 2013, Sean Eddy at Harvard University proposed inserting random synthetic DNA into human cells to establish a baseline for activity. Making large amounts of synthetic DNA proved costly, but researchers Brett Adey and Austen Ganley at the University of Auckland in New Zealand found a natural alternative. They analyzed human-plant hybrid cells created in Japan, which contain 35 million base pairs of DNA from thale cress (Arabidopsis thaliana).

Plants and animals diverged from a common ancestor at least 1.6 billion years ago, making the plant DNA effectively random from a human perspective, as mutations have altered every site multiple times. Adey and Ganley measured transcription start sites—points where DNA is copied into RNA—in the non-coding regions. They found about 80 percent as many start sites per kilobase in the plant DNA compared to human non-coding DNA.

"A large amount can simply be explained by background noise," Adey said. "This seems to be broadly consistent with the junk DNA idea."

The results indicate that most observed activity, as reported by ENCODE, is noise without function. "This is an excellent demonstration of how biology is, indeed, noisy," commented Chris Ponting at the University of Edinburgh. Dan Graur at the University of Houston called it "yet more experimental evidence confirming what has been obvious for years: most of the human genome is junk."

Human DNA showed 25 percent more activity, which the team cannot yet explain but plans to investigate using machine learning. The findings have not been published in a paper yet, but they bolster arguments that only about 5 percent of the genome is evolutionarily conserved and functional. Evolution tolerates noise, which can sometimes lead to useful innovations, Ganley noted.

Verwandte Artikel

Realistic microscopic view of DNA damage and real-time repair in a living cell using a new fluorescent sensor.
Bild generiert von KI

Scientists develop live-cell sensor to watch DNA repair in real time

Von KI berichtet Bild generiert von KI Fakten geprüft

Researchers at Utrecht University have engineered a fluorescent sensor that lets scientists observe DNA damage and repair in real time inside living cells and even within whole organisms. Built from components of a natural cellular protein, the tool provides continuous views of repair dynamics while minimizing interference with the cell’s own machinery. The work, reported in Nature Communications, could aid cancer research, drug testing and studies of aging.

Researchers at UNSW Sydney have identified around 150 functional DNA enhancers in human astrocytes that regulate genes associated with Alzheimer's disease. By testing nearly 1,000 potential switches using advanced genetic tools, the team revealed how non-coding DNA influences brain cell activity. The findings, published on December 18 in Nature Neuroscience, could aid in developing targeted therapies and improving AI predictions of gene control.

Von KI berichtet

Researchers have produced the most detailed maps yet of how human DNA folds and reorganizes in three dimensions and over time. This work, led by scientists at Northwestern University as part of the 4D Nucleome Project, highlights how genome architecture influences gene activity and disease risk. The findings, published in Nature, could accelerate the discovery of genetic mutations linked to illnesses like cancer.

Researchers at UNSW Sydney and St. Jude Children’s Research Hospital report a CRISPR-derived “epigenome editing” approach that turns genes on by removing DNA methylation marks rather than cutting DNA. In cell-based experiments, they show that promoter methylation can directly—and reversibly—silence fetal globin genes, a finding they say helps settle a long-running debate about whether methylation is causal or merely correlated with gene shutdown. The work points to a potential path toward safer therapies for sickle cell disease by reactivating fetal hemoglobin without creating DNA breaks.

Von KI berichtet

A 20-year experiment cloning mice has revealed that clones develop significantly more genetic mutations than naturally reproduced mice, accumulating to fatal levels after multiple generations. Researchers led by Teruhiko Wakayama at Yamanashi University in Japan found over 70 mutations per clone generation on average, three times higher than in controls. The findings, published in Nature Communications, raise concerns for applications in farming, conservation and de-extinction efforts.

Researchers at the Salk Institute have developed a detailed epigenetic catalog of human immune cells, showing how genetics and life experiences influence immune responses differently. The study, published in Nature Genetics, analyzed samples from 110 diverse individuals to distinguish inherited from environmental epigenetic changes. This work could lead to personalized treatments for infectious diseases.

Von KI berichtet

Researchers at the University of California, Berkeley have identified a methane-producing archaeon that interprets a standard stop codon in two ways, challenging a core principle of biology. The microbe, Methanosarcina acetivorans, sometimes adds an amino acid called pyrrolysine instead of halting protein synthesis. This flexibility may aid in metabolizing compounds linked to human health.

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen